all the information, none of the junk | biotech • healthcare • life sciences

The Immunex Alumni: Where Are They Now?

(Page 8 of 11)

Craig Parker, CEO, Vega Therapeutics

H. Stewart Parker, commercialization advisor, Washington Biotechnology & Biomedical Association

Arleen Paulino, executive director, PD, Amgen

Ray Paxton, research director

Jacques Peschon, senior research scientist, Institute for Systems Biology

Dean Pettit, executive director of process and product development, Amgen

Peggy V. Phillips, board member, Dynavax Technologies

Tom Philpott, service delivery manager, IBM @Amgen [Added: 4:40 pm, 1/4/11]

Kathy Picha, regulatory affairs manager, Dendreon

Nancy Plant, founder and managing member, Adkins, Plant, Elvins & Black

Dave Pon, director of finance, Fred Hutchinson Cancer Research Center

Karen Porter, business system analyst

Mike Preberowsky, independent pharmaceuticals professional

Steven Price, AVP, new products global strategic marketing, ImClone Systems, a subsidiary of Eli Lilly [Added: 12:40 pm, 1/6/11]

Cheryl Purdie, senior drug safety specialist, Human Genome Sciences

Brian Rabinovich, experimental diagnostic imaging group leader, genetic engineering and immunological imaging, UT MD Anderson Cancer Center [Added: 11:38 am, 1/22/11]

Seamus Ragan, scientist, Amgen

Carmen Rahm, assistant vice president for information technology, Central Washington University [Added: 4:40 pm, 1/4/11]

Fred Ramsdell, director, Novo Nordisk

Tom Ranken, president and CEO, Washington Clean Technology Alliance

Janet Rose Rea, clinical assistant professor, University of Washington, and founder, principal consultan, QARA Services [Added: 2:58 pm, 1/3/11]

Judy Rightmire, corporate communications associate, Dendreon

Bill Robertson, cGMP compliance consultant, V2 Bio-Consulting

Chris Rosenau, staffing manager, Microsoft

Eileen Roux, senior manager, Amgen

Timothy Ruane, chief executive officer, InSite Vision [Added: 4:49 pm, 1/4/11]

Abbe Rubin, secretary and treasurer, Sustainable Path Foundation

David Sabritt, president, Sabritt Solutions

William Sargent Jr., vice president of investor relations and communications, Auxilium Pharmaceuticals

Deanna Hill Saxbe, senior associate, Amgen

Nancy Scherer, owner, Altis Medical and Scientific Writing [Updated: 7:40 pm, 1/12/11]

Gordon Schiff, principal database administrator, Amgen

Ann Schmierer, strategic corporate liaison for the Georgia Institute of Technology

Dale Scott, program director, Seattle Genetics

Suzy Scott, owner, A Well Planned Event

Su Searle, corporate facilities maintenance planner/scheduler, Dendreon [Added: 3 pm, 1/13/11]

Kurt Shanebeck, scientist, Allozyne [Added: 12:40 pm, 1/6/11] … Next Page »

Single Page Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 previous page

By posting a comment, you agree to our terms and conditions.

  • Ajamete Kaykas

    Here are a few more that were forgotten;

    Jurgen Mulberg, Scientist Novartis Vaccine Research

    Pam Smolak, Scientist VLST

    Tom Cox, Scientist Novo Nordisk

    Ajamete Kaykas, Director Allen Institute for Brain Science

  • Thanks Ajamete. I’ve added those people to the list above, and have added the most recent titles I see. I don’t see Mullberg’s new title with Novartis on LinkedIn, and based on her LinkedIn profile, Pam Smolak looks to be no longer with VLST.

    Like I said above in the story, if anyone wants to chime in with more updated titles, please let me know and I’ll make the change.

  • As previous Immunex employee, I hold fond memories and just read an article about my dear old boss, Doug Williams who just accepted a new position as Executive V.P. of Biogen Idec

  • Diane Kolb

    Luke, thanks for the great articles! I too read about Doug Williams and am happy to hear he’s heading back to R&D. So many talents came together under one roof at Immunex. To date, I continue to say that I have had a great career in my chosen path with many wonderful people…but so far, none has come close to the Immunex family.

  • Stephen Cole

    Thanks for this wonderful summary of our Immunex colleagues’ post-Imnx lives. Wonderful.

    Immunex was the start of my career in IT. After completing my MBA post-Amgen acquisition, I have managed in a series of IT organizations, inlcuding EMC, SGI, Commvault and now Symantec.

    I will forever be indebted to Immunex for the opportunity, the environment and the wonderful professionals that I met there.

  • Stephen—thanks for the comment. I can’t help but wonder what you think it was about the culture that made Immunex so special, and how it’s different from many biotech workplaces of today. I’d love to hear from other Immunoids on that one too.

  • I’m an ex-Immunoid. I’m consulting in pathology in San Diego. Baloa BioConsulting, LLC

  • Suzen

    Hi Luke.
    I was with Immunex in Bothell before the “Baby Poster” was released. I did stay with Amgen when we got bought, and moved to the Helix site on the waterfront. Many years have gone by and I have found myself in Denderon with other great collegues. I am the Corp. Facilities Maintenace Planner/Scheduler. Keith LaChappelle is here too. After he left when the “Baby Poster” came out, he struck out on his own and developed the http://www.chimpsanctuarynw.org. He has since come back into the BioTech world and is now my boss as the Corp. Facilities Manager here in Seattle. Small world.
    Hey Immuniods, wanna hook up for a meet up @ Maggies? It’s been so long! I’m also on LinkIN, find me! Happy New Year!

  • Cathy McSharry

    I worked at Immunex from 1996 to 2002 and loved every minute of it. There will never be another Immunex. It was challenging yet rewarding. We were a family who worked together to accomplish the task at hand. I truly loved working at Immunex and miss it greatly. I agree with Diane, so many talents came together under one roof at Immunex.

  • Worked at Immunex from ’91-’94. Truly a dynamic environment composed of a work force with a collectively inspiring attitude. I am honored to have had the opportunity to experience it.

  • breana

    My mom was an immunoid, and she still works for Amgen. I’m doing a project for school on both companies, but I can’t find how many employees they had at any given time. Would somebody please tell me how many immunoids there were by 1982? Thank you very much.
    sincerely, Breana

  • From august to october of 1982, I spent 3 months there as a research consultant, in part because of my frienship w/ Jacques Bertoglio (an INSERM scientist : french équivalenbt of NIH) who worked in Immunex a couple of years. It was the very beginning of Immunex, then localized on one floor of 51, University. My best souvenir ? The TGIF ! Thank’s God It’s Friday.
    Chris and Steven were very kind to me, but I couldn’t accept their proposal because of a national commitment (Service National). Dommage ! What a shame.
    Where are they, and Chris, and Steven, and Larry (Lachman), and etc. I just found Diane Mochizuki on LinkedIn.


    Post-Scriptum : I found the mistake everybody made w/ IL-2. In fact, it’s very simple to make it works. We got a lysis syndrom w/ a multimetastaic lung carcinoma just adding 2 very spécific oligo-elements. Mysterious enough, isn’t it ?